BMO Capital Maintains Outperform on Converge Tech Solns, Lowers Price Target to C$7.5
BMO Capital analyst Deepak Kaushal maintains Converge Tech Solns (TSX:CTS) with a Outperform and lowers the price target from C$8 to C$7.5.
TD Securities Upgrades Converge Tech Solns to Buy, Lowers Price Target to C$6.5
TD Securities analyst David Kwan upgrades Converge Tech Solns (TSX:CTS) from Hold to Buy and lowers the price target from C$8.5 to C$6.5.
BMO Capital Initiates Coverage On Converge Tech Solns with Outperform Rating, Announces Price Target of C$9
BMO Capital analyst Deepak Kaushal initiates coverage on Converge Tech Solns (TSX:CTS) with a Outperform rating and announces Price Target of C$9.